Tacrolimus-Associated Calcium Pyrophosphate Crystal Arthritis in a Kidney Transplant Recipient: An Underrecognized...

Area of Science:

• Nephrology
• Rheumatology
• Transplant Medicine

Background:

• Tacrolimus is a vital immunosuppressant for renal transplant recipients.
• Calcium pyrophosphate deposition disease (CPPD) is a crystal-induced arthropathy.
• The association between tacrolimus and CPPD in transplant patients requires further clinical attention.

Purpose of the Study:

• To highlight the potential for tacrolimus-associated CPPD in renal transplant recipients.
• To emphasize the importance of timely diagnosis and management of CPPD in this population.

Main Methods:

• Case presentation of a renal transplant recipient with arthritis.
• Review of clinical presentation, diagnostic process, and treatment outcomes.

Main Results:

• The patient presented with arthritis, a potential manifestation of CPPD.
• Delayed diagnosis of tacrolimus-associated CPPD led to symptom progression and disability.

Conclusions:

• Renal transplant providers must consider tacrolimus-associated CPPD in patients with arthritis.
• Increased clinical awareness is essential to prevent avoidable disability in transplant recipients.